Dexmedetomidine group

( DrugBank: Dexmedetomidine / KEGG DRUG: Dexmedetomidine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
70	広範脊柱管狭窄症	3

70. 広範脊柱管狭窄症

臨床試験数 : 95 / 薬物数 : 169 - (DrugBank : 61) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 90

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02902380 (ClinicalTrials.gov)	September 27, 2016	6/9/2016	The Effect of Dexmedetomidine on Neuroendocrine Stress Hormone Release and Heart Rate Variability in ...		Spinal Stenosis	Drug: dexmedetomidine group;Drug: control group	Yonsei University	NULL	Completed	20 Years	70 Years	All	52	N/A	Korea, Republic of
2	EUCTR2015-002694-37-FI (EUCTR)	01/09/2016	04/01/2016	Dexmedetomidine is a drug that is used mainly for sedation in the intensive care unit. Purpose of th ...	Dexmedetomidine infusion in pain management during low back surgeryDexmedetomidine is an alpha-2-adr ...	Low back pain, Discus prolapse, Spinal stenosis;Therapeutic area: Analytical, Diagnostic and Therape ...	Trade Name: Dexmedetomidine Product Name: Dexdor INN or Proposed INN: DEXMEDETOMIDINE	Kuopio University hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: no Male: yes			Finland
3	NCT01377623 (ClinicalTrials.gov)	September 2010	3/1/2011	Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar ...	Pilot Study on the Effect of Dexmedetomidine on Inflammatory Responses in Patients Undergoing Lumbar ...	Spinal Stenosis;Inflammation	Drug: Dexmedetomidine group;Drug: Placebo group	New York University School of Medicine	Hospira, now a wholly owned subsidiary of Pfizer	Terminated	18 Years	N/A	All	66	N/A	United States

First Previous1Next Last